World's Best Scientists 2026 revealed!
Christos J. Petropoulos

Christos J. Petropoulos

D-Index & Metrics

Microbiology

D-Index
87
Citations
26401
World Ranking
800
National Ranking
370

Medicine

D-Index
89
Citations
28764
World Ranking
12697
National Ranking
6492

Christos J. Petropoulos publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Christos J. Petropoulos sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 251 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Christos J. Petropoulos D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Christos J. Petropoulos sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 87 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Christos J. Petropoulos is a researcher affiliated with LabCorp in the United States, specializing in medicine with a focus on infectious diseases. Their research portfolio comprises over 200 publications, primarily concentrating on infectious diseases, neurology, virology, molecular biology, and epidemiology.

Petropoulos's recent scholarly contributions include research on SARS-CoV-2 and COVID-19, with a particular emphasis on the long-term effects and clinical aspects of the virus. Significant publications are:

  • Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection (2021, Nature Medicine)
  • Multiple early factors anticipate post-acute COVID-19 sequelae (2022, Cell)
  • Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection (2021, The Journal of Infectious Diseases)
  • Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms (2021, Cell Reports)
  • Chronic viral coinfections differentially affect the likelihood of developing long COVID (2022, Journal of Clinical Investigation)

Their published work often addresses topics related to SARS-CoV-2 and COVID-19 research, including clinical studies and investigations into long-term effects of COVID-19. Petropoulos has also contributed extensively to HIV research, covering areas such as HIV/AIDS drug development and treatment, as well as interventions targeting the disease. The main topics of their work are:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 detection and testing

Collaborations have been an integral part of Petropoulos's research career. Frequent co-authors include Ahmed Chenna, John Winslow, Terri Wrin, Steven G. Deeks, and Michael J. Peluso, with co-authorship counts ranging from 28 to 38 publications per collaborator.

Petropoulos's work is prominently published in leading venues within medical and biological sciences. They have multiple publications across the following journals:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neurology
  • Open Forum Infectious Diseases
  • Nature Communications
  • The Journal of Infectious Diseases

Best Publications

  • Rapid evolution of the neutralizing antibody response to HIV type 1 infection

    Douglas D. Richman;Terri Wrin;Susan J. Little;Christos J. Petropoulos

  • A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

    Christos J. Petropoulos;Neil T. Parkin;Kay L. Limoli;Yolanda S. Lie

  • Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

    James M. Binley;Terri Wrin;Bette Korber;Michael B. Zwick

  • Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

    Steven G. Deeks;Terri Wrin;Teri Liegler;Rebecca Hoh

  • Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy

    Florencia Pereyra;Marylyn M. Addo;Daniel E. Kaufmann;Yang Liu

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

    K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  • Time trends in primary HIV-1 drug resistance among recently infected persons.

    Robert M. Grant;Frederick M. Hecht;Maria Warmerdam;Lea Liu

  • Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

    Frederick M. Hecht;Robert M. Grant;Christos J. Petropoulos;Beth Dillon

  • Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1

    Aran F. Labrijn;Pascal Poignard;Aarti Raja;Michael B. Zwick

  • Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV Infection

    Susan J. Little;Eric S. Daar;Richard T. D'Aquila;Philip H. Keiser

  • Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.

    Jeannette M. Whitcomb;Wei Huang;Signe Fransen;Kay Limoli

  • Advances in quantitative PCR technology: 5' nuclease assays.

    Yolanda S Lie;Christos J Petropoulos

  • Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

    Simon D. W. Frost;Terri Wrin;Davey M. Smith;Sergei L. Kosakovsky Pond

  • Expression of a cellular oncogene during liver regeneration.

    Michele Goyette;Christos J. Petropoulos;Peter R. Shank;Nelson Fausto

  • Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.

    Diane V. Havlir;Nick S. Hellmann;Christos J. Petropoulos;Jeannette M. Whitcomb

  • Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

    Barrett;S Belij-Rammerstorfer;C Dold;K J Ewer

  • Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

    Michael J Peluso;Scott Lu;Alex F Tang;Matthew S Durstenfeld

  • Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines.

    John R. Mascola;Patricia D'Souza;Peter Gilbert;Beatrice H. Hahn

  • Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.

    Jeannette M. Whitcomb;Neil T. Parkin;Colombe Chappey;Nicholas S. Hellmann

  • Evidence for Positive Epistasis in HIV-1

    Sebastian Bonhoeffer;Colombe Chappey;Neil T. Parkin;Jeanette M. Whitcomb

  • Reduced antiretroviral drug susceptibility among patients with primary HIV infection, JAMA 282: 1142-9

    Susan J. Little;E. S. Daar;R. T. D'Aquila;P. H. Keiser

Frequent Co-Authors

Neil Parkin
Neil Parkin Data First COnsulting
Terri Wrin
Terri Wrin LabCorp (United States)
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Robert M. Grant
Robert M. Grant University of California, San Francisco
Susan J. Little
Susan J. Little University of California, San Diego
Bruce D. Walker
Bruce D. Walker Harvard University
Jeffrey N. Martin
Jeffrey N. Martin University of California, San Francisco
Teri Liegler
Teri Liegler University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities. Some programs are designed to be accessible, even for those with past legal challenges, making degrees for felons a valuable resource to consider.

Beyond traditional lab roles, health-focused careers like becoming a functional medicine nurse practitioner offer rewarding paths. Understanding the functional medicine NP salary can help guide decisions around further education and specialization.

Healthcare administration and data management are also prominent fields. Certifications and degrees preparing students as certified professional coders provide a stable career with clear advancement. Researching the certified professional coder salary and career paths is essential for those drawn to this specialty.

Additionally, roles such as health information managers combine healthcare knowledge with technology skills. Learning about health information management jobs salary can give up-to-date insights into this growing field.

By exploring these pathways and their corresponding credentials, microbiology students can align their academic interests with viable, well-compensated careers.

Best Scientists Citing Christos J. Petropoulos

Trending Scientists

Recently Published Articles